RE:RE:RE:sent a pm to kbc this morning - no responseKayackerBC, "I sold some and will wait it out with the rest".
Reminds me of this post before the stock collapsed...
Hey POOF, speaking of past posts, here's a few of yours (as Digitel) back in 2017.
I would encourage folks to read through them. It was a period of non-stop bashing that abruptly ended, then it was back to non-stop pumping. Look at the title on the first one. Is that not true today?
POOF could just as easily be bashing and FUDing like this since the deal was announced................. if it aligned with his stock position. But hang on, he'll be back to non-stop bashing not too far down the road.
-------------------------------------------------------------
"Now there's a great big opinion being expressed in the market!"
November 29, 2017
RE:Down 4¢ on 2,250 shares.
It's the whole world, including the insiders, not stepping up to buy the shares even one cent higher and letting it fall. That's the opinion that should concern us; especially at this price level. Where's the liquidity?
And if BTI is having a hard time generating liquidity at these prices, including from insiders, what price may they need to finance/dilute given the dwindling cash position? And why is the stock closer to its 52-week low than the high of last year given the new management. The goal should have been to get the warrant money on the strength of the new management team and the validation and the plan. Why isn't the market showing buy-in but instead 'negative validation' over seven months into the new leadership and plans unfolding?
And what happened with Shire, Medimmune, Astellas, Scarpa, the foot dragging concerning the Herceptin product given an IND filing was to be filed in 2015, and "$18 and 4, maybe more", fireworks, and hockey stick like revenue, Shadow Lake Group, etc.? What about those 'bids' - the bids of industry? Why didn't Gubiz ever buy shares?
How easily will BTI be able to finance given current liquidity and the insiders lack of skin in the game given their stock purchases? drjekl mentions how the financings have been successively lower over the years. If industry has voiced its opinion, and management has only purchased the stock it has after all of the talks with industry and with its insider knowledge, where does that leave the market? Have we seen all they have?
This company appears to have lost more licensing deals vs. those still active(Medimmune, Astellas, vs. Vaccinex); but what is up with Vaccinex over one year after it signed its deal that it never even bothered to press release on its website?
Why has this been so difficult vs. expectations?
------------------------------------------------------------------------------------
Breaks 200-day moving average
November 28, 2017
The company is much closer to its 52-week low than its high of last year. Has the company experienced negative validation as it runs low on cash and into tax loss selling?
------------------------------------------------------------------------
RE:RE:US Market is waking up a bit
November 2017
When bagholders are excited doesn't that mean they are about to get another bag to hold? Are the new insiders excited given the number of shares they've bought since joining? I wonder how many companies have less skin in the game than BTI 2.0?